A study of buspirone coprescribed with histamine H2-receptor antagonists in anxious outpatients.
In a study of a large cohort of patients suffering from anxiety symptoms and treated with the new anxiolytic, buspirone, 0.5% were found to be receiving concomitant histamine H2-receptor antagonist therapy. A study of this subgroup showed that no drug interaction occurred.
Levine
S
S
Oldham & District General Hospital, U.K.
Napoliello
M J
MJ
D001008:Anxiety Disorders / Q000188:drug therapy*; D002065:Buspirone / Q000627:therapeutic use*; D002927:Cimetidine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000517:prevention & control; D011602:Psychophysiologic Disorders / Q000517:prevention & control; D011899:Ranitidine / Q000627:therapeutic use*
D002927:Cimetidine; D011899:Ranitidine; D002065:Buspirone